PRESS RELEASE published on 04/17/2023 at 18:00, 2 years 9 months ago Abivax reports two-year efficacy and safety data of obefazimod phase 2b maintenance trial in ulcerative colitis
PRESS RELEASE published on 04/05/2023 at 19:30, 2 years 9 months ago Abivax appoints Marc de Garidel as Chief Executive Officer and Interim Board Chair
PRESS RELEASE published on 03/16/2023 at 18:30, 2 years 10 months ago Abivax adjusts its 2023 Financial Communication Calendar
PRESS RELEASE published on 03/13/2023 at 12:00, 2 years 10 months ago Abivax does not hold any cash or otherwise have any deposits at SVB or at any other U.S. financial institution
PRESS RELEASE published on 02/23/2023 at 20:00, 2 years 11 months ago Abivax publishes a prospectus in the context of its capital increase
PRESS RELEASE published on 02/22/2023 at 18:05, 2 years 11 months ago Abivax announces successful oversubscribed EUR 130M cross-over financing at market price with top-tier US and European biotech investors
PRESS RELEASE published on 02/17/2023 at 08:00, 2 years 11 months ago Abivax appoints Dr. Sheldon Sloan, M.D., as Chief Medical Officer
PRESS RELEASE published on 02/14/2023 at 18:00, 2 years 11 months ago Abivax to present blood and rectal tissue data from UC patients treated with obefazimod at the 18th Congress of ECCO
PRESS RELEASE published on 01/31/2023 at 18:00, 2 years 11 months ago ABIVAX: NOTICE TO HOLDERS OF BONDS CONVERTIBLE AND/OR EXCHANGEABLE INTO NEW AND/OR EXISTING SHARES (OCEANES) WITH A NOMINAL VALUE OF EUR 24,999,975.99
PRESS RELEASE published on 01/05/2023 at 08:00, 3 years ago Abivax publishes novel data with respect to obefazimod’s anti-inflammatory mechanism of action
Published on 01/30/2026 at 14:00, 5 hours 34 minutes ago CCL to Hold Live Webcast to Discuss Fourth Quarter and Year End 2025 Results, Thursday, February 26, 2026, at 7:30 a.m. ET
Published on 01/30/2026 at 08:35, 10 hours 59 minutes ago Alaska Energy Metals Announces Closing Of Life Offering of Units
Published on 01/30/2026 at 08:00, 11 hours 34 minutes ago Troubadour Resources Intercepts Target Mineralization Near Surface during Phase 1 of the Multi-Phase Drill Program at Senneville Gold-Silver-Copper Property
Published on 01/30/2026 at 02:15, 17 hours 19 minutes ago Canex Metals Announces Success of Gold Basin Take-Over Bid, Extension of the Partial Revocation of the Cease-Trade Order Imposed on Gold Basin, Waiver of All Remaining Conditions, Initiation of the Share Take Up Process, and Mandatory 10-Day Extension
Published on 01/30/2026 at 00:00, 19 hours 34 minutes ago LIR Life Sciences Reports Positive Interim Preclinical Results from Comparative Animal Study of Novel CPP-Enabled Transdermal Delivery of GLP/GIP-Based Therapies
Published on 01/30/2026 at 18:31, 1 hour 3 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 01/30/2026 at 17:45, 1 hour 49 minutes ago Schneider Electric launches a capital increase reserved for employees
Published on 01/29/2026 at 18:00, 1 day 1 hour ago GUILLEMOT CORPORATION: FULL-YEAR 2025 CONSOLIDATED TURNOVER UP 2%
Published on 01/29/2026 at 17:45, 1 day 1 hour ago LANSON-BCC ANNOUNCES 2025 REVENUES AND FINALISES THE ACQUISITION OF HEIDSIECK & C° MONOPOLE
Published on 01/29/2026 at 17:45, 1 day 1 hour ago Cegedim generated LFL revenue growth of 1.1% in 2025
